Dupont Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-101,853
| Closed | -$12.3M | – | 78 |
|
|
2026
Q1 | $12.3M | Buy |
+101,853
| New | +$11.8M | 1.39% | 23 |
|
|
2023
Q3 | – | Sell |
-9,990
| Closed | -$1.15M | – | 445 |
|
|
2023
Q2 | $1.15M | Sell |
9,990
-8,778
| -47% | -$997K | 0.06% | 158 |
|
|
2023
Q1 | $2M | Sell |
18,768
-3,094
| -14% | -$334K | 0.1% | 108 |
|
|
2022
Q4 | $2.43M | Sell |
21,862
-6,307
| -22% | -$645K | 0.11% | 122 |
|
|
2022
Q3 | $2.43M | Sell |
28,169
-17,857
| -39% | -$1.59M | 0.14% | 133 |
|
|
2022
Q2 | $4.2M | Buy |
46,026
+28,121
| +157% | +$2.49M | 0.2% | 78 |
|
|
2022
Q1 | $1.47M | Sell |
17,905
-11,586
| -39% | -$913K | 0.06% | 339 |
|
|
2021
Q4 | $2.26M | Sell |
29,491
-4,877
| -14% | -$388K | 0.08% | 227 |
|
|
2021
Q3 | $2.58M | Sell |
34,368
-41,845
| -55% | -$3.18M | 0.08% | 255 |
|
|
2021
Q2 | $5.93M | Sell |
76,213
-19,161
| -20% | -$1.43M | 0.14% | 112 |
|
|
2021
Q1 | $7.02M | Sell |
95,374
-184,881
| -66% | -$13.6M | 0.17% | 97 |
|
|
2020
Q4 | $21.9M | Sell |
280,255
-7,762
| -3% | -$594K | 0.47% | 29 |
|
|
2020
Q3 | $22.8M | Buy |
288,017
+12,925
| +5% | +$1.01M | 0.5% | 34 |
|
|
2020
Q2 | $20.3M | Sell |
275,092
-44,420
| -14% | -$3.34M | 0.45% | 36 |
|
|
2020
Q1 | $23.5M | Buy |
319,512
+22,451
| +8% | +$1.76M | 0.56% | 21 |
|
|
2019
Q4 | $25.8M | Buy |
297,061
+6,423
| +2% | +$528K | 0.58% | 21 |
|
|
2019
Q3 | $23.3M | Sell |
290,638
-65,176
| -18% | -$5.22M | 0.54% | 19 |
|
|
2019
Q2 | $28.5M | Sell |
355,814
-38,737
| -10% | -$2.97M | 0.65% | 20 |
|
|
2019
Q1 | $31.3M | Buy |
394,551
+43,867
| +13% | +$3.28M | 0.72% | 18 |
|
|
2018
Q4 | $25.6M | Buy |
350,684
+65,209
| +23% | +$4.6M | 0.63% | 21 |
|
|
2018
Q3 | $19.3M | Sell |
285,475
-45,209
| -14% | -$2.88M | 0.43% | 40 |
|
|
2018
Q2 | $19.2M | Sell |
330,684
-33,314
| -9% | -$1.88M | 0.45% | 28 |
|
|
2018
Q1 | $18.9M | Buy |
363,998
+9,772
| +3% | +$528K | 0.46% | 31 |
|
|
2017
Q4 | $19M | Sell |
354,226
-105,537
| -23% | -$5.85M | 0.44% | 34 |
|
|
2017
Q3 | $28.1M | Sell |
459,763
-4,349
| -0.9% | -$264K | 0.64% | 20 |
|
|
2017
Q2 | $28.4M | Sell |
464,112
-24,413
| -5% | -$1.49M | 0.63% | 20 |
|
|
2017
Q1 | $29.6M | Sell |
488,525
-75,700
| -13% | -$4.59M | 0.66% | 18 |
|
|
2016
Q4 | $31.7M | Buy |
564,225
+72,983
| +15% | +$4.27M | 0.71% | 18 |
|
|
2016
Q3 | $29.3M | Sell |
491,242
-75,776
| -13% | -$4.43M | 0.66% | 19 |
|
|
2016
Q2 | $31.2M | Sell |
567,018
-15,402
| -3% | -$820K | 0.69% | 16 |
|
|
2016
Q1 | $29.4M | Buy |
582,420
+110,790
| +23% | +$5.43M | 0.67% | 19 |
|
|
2015
Q4 | $23.8M | Sell |
471,630
-174,710
| -27% | -$8.81M | 0.57% | 30 |
|
|
2015
Q3 | $30.5M | Sell |
646,340
-89,705
| -12% | -$4.77M | 0.77% | 14 |
|
|
2015
Q2 | $40M | Sell |
736,045
-125,960
| -15% | -$7.06M | 0.87% | 20 |
|
|
2015
Q1 | $47.3M | Sell |
862,005
-169,513
| -16% | -$9.6M | 0.93% | 13 |
|
|
2014
Q4 | $55.9M | Buy |
1,031,518
+82,928
| +9% | +$4.62M | 1.03% | 15 |
|
|
2014
Q3 | $53.7M | Sell |
948,590
-507,406
| -35% | -$28.5M | 0.93% | 12 |
|
|
2014
Q2 | $80.4M | Sell |
1,455,996
-146,019
| -9% | -$7.97M | 1.32% | 11 |
|
|
2014
Q1 | $86.8M | Sell |
1,602,015
-196,055
| -11% | -$10.2M | 1.4% | 11 |
|
|
2013
Q4 | $85.9M | Buy |
1,798,070
+78,041
| +5% | +$3.57M | 1.5% | 8 |
|
|
2013
Q3 | $78.1M | Buy |
1,720,029
+249,030
| +17% | +$11.4M | 1.43% | 13 |
|
|
2013
Q2 | $65.2M | Buy |
+1,470,999
| New | +$65.7M | 1.22% | 13 |
|
Other funds holding MRK
Dupont Capital Management's MRK Position: Q2 2026 in Review
Dupont Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 101,853 shares — an estimated $12.3M sold.
Dupont Capital Management first reported a position in MRK in Q2 2013 and held it in 42 quarters. The position peaked at $86.8M in Q1 2014. 2,365 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Dupont Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Dupont Capital Management sold 101,853 Merck shares in Q2 2026, an estimated $12.3M.
- Dupont Capital Management first reported a position in Merck in Q2 2013 and held it in 42 quarters.
- Dupont Capital Management's Merck position peaked at $86.8M in Q1 2014.
- 2,365 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.